Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II-induced cutaneous inflammation - Girish Gilly Munavalli, MD, MHS, FACMS; Siri Knutsen-Larson, MD; Mary P. Lupo, MD; Roy G. Geronemus, MD (Elsevier, 2021)